BIRMINGHAM, Ala. – A federal judge today sentenced a Springville couple involved in a St. Clair County pill mill scheme, announced Drug Enforcement Administration Special Agent in Charge of the New Orleans Division Brad L. Byerley, U.S. Attorney Jay E. Town, and IRS-Criminal Investigations Atlanta Field Office Special Agent in...

PHOENIX – The DEA announces the sentencing of Fany Madrigal-Lopez, 45, to 12 years in prison and five years of supervised release, following a hearing in federal court yesterday. Madrigal-Lopez previously pleaded guilty in April 2018, to two federal drug charges, including the distribution of fentanyl resulting in death. The...

LITTLE ROCK, Ark. – The Drug Enforcement Administration, in conjunction with federal and state prosecutors, announced today an unprecedented enforcement action spanning across the state of Arkansas in a combined effort to reverse the horrible effects on communities produced by violent drug traffickers. As part of this effort, dubbed Operation...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...

MONTGOMERY, Ala. – Dr. Gilberto Sanchez, 56, of Montgomery, Alabama, was sentenced to serve 12 years and 1 month in prison for prescribing unnecessary controlled substances to his patients, committing health care fraud, and laundering money, announced Drug Enforcement Administration Assistant Special Agent in Charge Bret Hamilton and United States...

BIRMINGHAM, Ala. – The Department of Justice has reached an agreement with CVS Pharmacy, Inc. to resolve violations of the federal Controlled Substances Act and its implementing regulations at CVS Pharmacy locations throughout the Northern District of Alabama, announced DEA Special Agent in Charge Stephen G. Azzam and U.S. Attorney...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...